Overview
Announcements

Ordinary Rebalance | Solactive Transatlantic Healthcare Equity Index | Effective Date 10th January 2023

In the ordinary rebalance, the following index composition will be implemented effective open 10.01.2023:

3M COMPANY
ABBOTT LABORATORIES
ABBVIE INC
ALCON INC
AMGEN INC
BAYER AG
BECTON DICKINSON AND CO
BIOMARIN PHARMACEUTICAL INC
BIOMERIEUX
BRISTOL-MYERS SQUIBB CO
CIGNA CORP
ELEVANCE HEALTH INC
ELI LILLY & CO
ENCOMPASS HEALTH CORP
ENSIGN GROUP INC
ESSILORLUXOTTICA
GENMAB A/S
GILEAD SCIENCES INC
GSK PLC
HAEMONETICS CORP
HOLOGIC INC
HUMANA INC
INCYTE CORP
IRONWOOD PHARMACEUTICALS INC
JAZZ PHARMACEUTICALS PLC
JOHNSON & JOHNSON
LABORATORY CRP OF AMER HLDGS
LHC GROUP INC
MEDTRONIC PLC
MERCK & CO. INC.
MERCK KGAA
MOLINA HEALTHCARE INC
NEUROCRINE BIOSCIENCES INC
NOVARTIS AG
NOVO NORDISK A/S
ORGANON & CO
ORION OYJ CLASS B
PFIZER INC
PRESTIGE CONSUMER HEALTHCARE INC
QIAGEN NV
QUEST DIAGNOSTICS INC
RESMED INC
ROCHE HOLDING AG
ROYALTY PHARMA PLC- CL A
SANOFI SA
STRYKER CORP
UCB SA
UNITED THERAPEUTICS CORP
UNITEDHEALTH GROUP INC
ZIMMER BIOMET HOLDINGS INC